Seagate Technology Holdings plc — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Seagate Technology Holdings plc filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Jun 30, 2023 | $7.38B | Aug 4, 2023 |
| FY2023 | Jul 1, 2022 | $11.66B | Aug 4, 2023 |
| FY2023 | Jul 2, 2021 | $10.68B | Aug 4, 2023 |
| FY2022 | Jul 3, 2020 | $10.51B | Aug 5, 2022 |
| FY2021 | Jun 28, 2019 | $10.39B | Aug 6, 2021 |
| FY2020 | Jun 29, 2018 | $11.18B | Aug 7, 2020 |
| FY2019 | Jun 30, 2017 | $10.77B | Aug 2, 2019 |
| FY2018 | Jul 1, 2016 | $11.16B | Aug 3, 2018 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2027 | Jun 27, 2025 | $9.10B | Aug 1, 2025 |
| FY2027 | Jun 28, 2024 | $6.55B | Aug 1, 2025 |
| FY2027 | Jun 30, 2023 | $7.38B | Aug 1, 2025 |
| FY2024 | Jul 1, 2022 | $11.66B | Aug 2, 2024 |
| FY2023 | Jul 2, 2021 | $10.68B | Aug 4, 2023 |
| FY2022 | Jul 3, 2020 | $10.51B | Aug 5, 2022 |
| FY2021 | Jun 28, 2019 | $10.39B | Aug 6, 2021 |
| FY2020 | Jun 29, 2018 | $11.18B | Aug 7, 2020 |
| FY2019 | Jun 30, 2017 | $10.77B | Aug 2, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Jun 30, 2017 | $10.77B | Aug 4, 2017 |
| FY2017 | Jul 1, 2016 | $11.16B | Aug 4, 2017 |
| FY2017 | Jul 3, 2015 | $13.74B | Aug 4, 2017 |
| FY2016 | Jun 27, 2014 | $13.72B | Aug 5, 2016 |
| FY2015 | Jun 28, 2013 | $14.35B | Aug 12, 2015 |
| FY2014 | Jun 29, 2012 | $14.94B | Aug 8, 2014 |
| FY2013 | Jul 1, 2011 | $10.97B | Aug 8, 2013 |
| FY2012 | Jul 2, 2010 | $11.40B | Aug 9, 2012 |
| FY2011 | Jul 3, 2009 | $9.81B | Aug 17, 2011 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2027 | Jun 27, 2025 | $1.47B | Aug 1, 2025 |
| FY2027 | Jun 28, 2024 | $335.00M | Aug 1, 2025 |
| FY2027 | Jun 30, 2023 | ($529.00M) | Aug 1, 2025 |
| FY2024 | Jul 1, 2022 | $1.65B | Aug 2, 2024 |
| FY2023 | Jul 2, 2021 | $1.31B | Aug 4, 2023 |
| FY2022 | Jul 3, 2020 | $1.00B | Aug 5, 2022 |
| FY2021 | Jun 28, 2019 | $2.01B | Aug 6, 2021 |
| FY2020 | Jun 29, 2018 | $1.18B | Aug 7, 2020 |
| FY2019 | Jun 30, 2017 | $772.00M | Aug 2, 2019 |
| FY2018 | Jul 1, 2016 | $248.00M | Aug 3, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2027 | Jun 27, 2025 | $1.89B | Aug 1, 2025 |
| FY2027 | Jun 28, 2024 | $452.00M | Aug 1, 2025 |
| FY2027 | Jun 30, 2023 | ($342.00M) | Aug 1, 2025 |
| FY2024 | Jul 1, 2022 | $1.96B | Aug 2, 2024 |
| FY2023 | Jul 2, 2021 | $1.49B | Aug 4, 2023 |
| FY2022 | Jul 3, 2020 | $1.30B | Aug 5, 2022 |
| FY2021 | Jun 28, 2019 | $1.49B | Aug 6, 2021 |
| FY2020 | Jun 29, 2018 | $1.63B | Aug 7, 2020 |
| FY2019 | Jun 30, 2017 | $1.05B | Aug 2, 2019 |
| FY2018 | Jul 1, 2016 | $445.00M | Aug 3, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2027 | Jun 27, 2025 | $724.00M | Aug 1, 2025 |
| FY2027 | Jun 28, 2024 | $654.00M | Aug 1, 2025 |
| FY2027 | Jun 30, 2023 | $797.00M | Aug 1, 2025 |
| FY2024 | Jul 1, 2022 | $941.00M | Aug 2, 2024 |
| FY2023 | Jul 2, 2021 | $903.00M | Aug 4, 2023 |
| FY2022 | Jul 3, 2020 | $973.00M | Aug 5, 2022 |
| FY2021 | Jun 28, 2019 | $991.00M | Aug 6, 2021 |
| FY2020 | Jun 29, 2018 | $1.03B | Aug 7, 2020 |
| FY2019 | Jun 30, 2017 | $1.23B | Aug 2, 2019 |
| FY2018 | Jul 1, 2016 | $1.24B | Aug 3, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2027 | Jun 27, 2025 | $561.00M | Aug 1, 2025 |
| FY2027 | Jun 28, 2024 | $460.00M | Aug 1, 2025 |
| FY2027 | Jun 30, 2023 | $491.00M | Aug 1, 2025 |
| FY2024 | Jul 1, 2022 | $559.00M | Aug 2, 2024 |
| FY2023 | Jul 2, 2021 | $502.00M | Aug 4, 2023 |
| FY2022 | Jul 3, 2020 | $473.00M | Aug 5, 2022 |
| FY2021 | Jun 28, 2019 | $453.00M | Aug 6, 2021 |
| FY2020 | Jun 29, 2018 | $562.00M | Aug 7, 2020 |
| FY2019 | Jun 30, 2017 | $606.00M | Aug 2, 2019 |
| FY2018 | Jul 1, 2016 | $635.00M | Aug 3, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2027 | Jun 27, 2025 | $1.08B | Aug 1, 2025 |
| FY2027 | Jun 28, 2024 | $918.00M | Aug 1, 2025 |
| FY2027 | Jun 30, 2023 | $942.00M | Aug 1, 2025 |
| FY2024 | Jul 1, 2022 | $1.66B | Aug 2, 2024 |
| FY2023 | Jul 2, 2021 | $1.63B | Aug 4, 2023 |
| FY2022 | Jul 3, 2020 | $1.71B | Aug 5, 2022 |
| FY2021 | Jun 28, 2019 | $1.76B | Aug 6, 2021 |
| FY2020 | Jun 29, 2018 | $2.11B | Aug 7, 2020 |
| FY2019 | Jun 30, 2017 | $1.92B | Aug 2, 2019 |
| FY2018 | Jul 1, 2016 | $1.68B | Aug 3, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2027 | Jun 27, 2025 | $265.00M | Aug 1, 2025 |
| FY2027 | Jun 28, 2024 | $254.00M | Aug 1, 2025 |
| FY2027 | Jun 30, 2023 | $316.00M | Aug 1, 2025 |
| FY2024 | Jul 1, 2022 | $381.00M | Aug 2, 2024 |
| FY2023 | Jul 2, 2021 | $498.00M | Aug 4, 2023 |
| FY2022 | Jul 3, 2020 | $585.00M | Aug 5, 2022 |
| FY2021 | Jun 28, 2019 | $602.00M | Aug 6, 2021 |
| FY2020 | Jun 29, 2018 | $366.00M | Aug 7, 2020 |
| FY2019 | Jun 30, 2017 | $434.00M | Aug 2, 2019 |
| FY2018 | Jul 1, 2016 | $587.00M | Aug 3, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2027 | Jun 27, 2025 | $8.02B | Aug 1, 2025 |
| FY2027 | Jun 28, 2024 | $7.74B | Aug 1, 2025 |
| FY2024 | Jun 30, 2023 | $7.56B | Aug 2, 2024 |
| FY2023 | Jul 1, 2022 | $8.94B | Aug 4, 2023 |
| FY2022 | Jul 2, 2021 | $8.68B | Aug 5, 2022 |
| FY2021 | Jul 3, 2020 | $8.93B | Aug 6, 2021 |
| FY2020 | Jun 28, 2019 | $8.89B | Aug 7, 2020 |
| FY2019 | Jun 29, 2018 | $9.41B | Aug 2, 2019 |
| FY2018 | Jun 30, 2017 | $9.27B | Aug 3, 2018 |
| FY2017 | Jul 1, 2016 | $8.21B | Aug 4, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2027 | Jun 27, 2025 | $8.48B | Aug 1, 2025 |
| FY2027 | Jun 28, 2024 | $9.23B | Aug 1, 2025 |
| FY2024 | Jun 30, 2023 | $8.76B | Aug 2, 2024 |
| FY2023 | Jul 1, 2022 | $8.84B | Aug 4, 2023 |
| FY2022 | Jul 2, 2021 | $8.04B | Aug 5, 2022 |
| FY2021 | Jul 3, 2020 | $7.14B | Aug 6, 2021 |
| FY2020 | Jun 28, 2019 | $6.72B | Aug 7, 2020 |
| FY2019 | Jun 29, 2018 | $7.75B | Aug 2, 2019 |
| FY2018 | Jun 30, 2017 | $7.90B | Aug 3, 2018 |
| FY2017 | Jul 1, 2016 | $6.62B | Aug 4, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2027 | Jun 27, 2025 | ($453.00M) | Aug 1, 2025 |
| FY2027 | Jun 28, 2024 | ($1.49B) | Aug 1, 2025 |
| FY2027 | Jun 30, 2023 | ($1.20B) | Aug 1, 2025 |
| FY2027 | Jul 1, 2022 | $109.00M | Aug 1, 2025 |
| FY2024 | Jul 2, 2021 | $631.00M | Aug 2, 2024 |
| FY2023 | Jul 3, 2020 | $1.79B | Aug 4, 2023 |
| FY2022 | Jun 28, 2019 | $2.16B | Aug 5, 2022 |
| FY2021 | Jun 29, 2018 | $1.67B | Aug 6, 2021 |
| FY2020 | Jun 30, 2017 | $1.36B | Aug 7, 2020 |
| FY2019 | Jul 1, 2016 | $1.59B | Aug 2, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2027 | Jun 27, 2025 | $1.22B | Aug 1, 2025 |
| FY2027 | Jun 28, 2024 | $1.22B | Aug 1, 2025 |
| FY2024 | Jun 30, 2023 | $1.24B | Aug 2, 2024 |
| FY2023 | Jul 1, 2022 | $1.24B | Aug 4, 2023 |
| FY2022 | Jul 2, 2021 | $1.24B | Aug 5, 2022 |
| FY2021 | Jul 3, 2020 | $1.24B | Aug 6, 2021 |
| FY2020 | Jun 28, 2019 | $1.24B | Aug 7, 2020 |
| FY2019 | Jun 29, 2018 | $1.24B | Aug 2, 2019 |
| FY2019 | Jun 30, 2017 | $1.24B | Aug 2, 2019 |
| FY2018 | Jul 1, 2016 | $1.24B | Aug 3, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2027 | Jun 27, 2025 | ($8.15B) | Aug 1, 2025 |
| FY2027 | Jun 28, 2024 | ($8.96B) | Aug 1, 2025 |
| FY2024 | Jun 30, 2023 | ($8.67B) | Aug 2, 2024 |
| FY2023 | Jul 1, 2022 | ($7.12B) | Aug 4, 2023 |
| FY2022 | Jul 2, 2021 | ($6.31B) | Aug 5, 2022 |
| FY2021 | Jul 3, 2020 | ($4.90B) | Aug 6, 2021 |
| FY2020 | Jun 28, 2019 | ($4.35B) | Aug 7, 2020 |
| FY2019 | Jun 30, 2018 | ($4.66B) | Aug 2, 2019 |
| FY2019 | Jun 29, 2018 | ($4.70B) | Aug 2, 2019 |
| FY2018 | Jun 30, 2017 | ($4.77B) | Aug 3, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2027 | Jun 27, 2025 | $891.00M | Aug 1, 2025 |
| FY2027 | Jun 28, 2024 | $1.36B | Aug 1, 2025 |
| FY2027 | Jun 30, 2023 | $786.00M | Aug 1, 2025 |
| FY2024 | Jul 1, 2022 | $615.00M | Aug 2, 2024 |
| FY2023 | Jul 2, 2021 | $1.21B | Aug 4, 2023 |
| FY2022 | Jul 3, 2020 | $1.72B | Aug 5, 2022 |
| FY2022 | Jun 28, 2019 | $2.22B | Aug 5, 2022 |
| FY2021 | Jun 29, 2018 | $1.85B | Aug 6, 2021 |
| FY2020 | Jun 30, 2017 | $2.54B | Aug 7, 2020 |
| FY2019 | Jul 1, 2016 | $1.13B | Aug 2, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Jul 1, 2022 | $964.00M | Aug 4, 2023 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2027 | Jun 27, 2025 | 6 | Aug 1, 2025 |
| FY2027 | Jun 28, 2024 | 1 | Aug 1, 2025 |
| FY2027 | Jun 30, 2023 | (2) | Aug 1, 2025 |
| FY2024 | Jul 1, 2022 | 7 | Aug 2, 2024 |
| FY2023 | Jul 2, 2021 | 5 | Aug 4, 2023 |
| FY2022 | Jul 3, 2020 | 3 | Aug 5, 2022 |
| FY2021 | Jun 28, 2019 | 7 | Aug 6, 2021 |
| FY2020 | Jun 29, 2018 | 4 | Aug 7, 2020 |
| FY2019 | Jun 30, 2017 | 2 | Aug 2, 2019 |
| FY2018 | Jul 1, 2016 | 0 | Aug 3, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2027 | Jun 27, 2025 | 6 | Aug 1, 2025 |
| FY2027 | Jun 28, 2024 | 1 | Aug 1, 2025 |
| FY2027 | Jun 30, 2023 | (2) | Aug 1, 2025 |
| FY2024 | Jul 1, 2022 | 7 | Aug 2, 2024 |
| FY2023 | Jul 2, 2021 | 5 | Aug 4, 2023 |
| FY2022 | Jul 3, 2020 | 3 | Aug 5, 2022 |
| FY2021 | Jun 28, 2019 | 7 | Aug 6, 2021 |
| FY2020 | Jun 29, 2018 | 4 | Aug 7, 2020 |
| FY2019 | Jun 30, 2017 | 2 | Aug 2, 2019 |
| FY2018 | Jul 1, 2016 | 0 | Aug 3, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2027 | Jun 27, 2025 | 212.67M | Aug 1, 2025 |
| FY2024 | Jun 28, 2024 | 210.18M | Aug 2, 2024 |
| FY2023 | Jun 30, 2023 | 207.39M | Aug 4, 2023 |
| FY2023 | Jul 1, 2022 | 209.85M | Aug 4, 2023 |
| FY2022 | Jul 2, 2021 | 227.38M | Aug 5, 2022 |
| FY2022 | May 18, 2021 | 227.34M | Aug 5, 2022 |
| FY2021 | Jul 3, 2020 | 256.72M | Aug 6, 2021 |
| FY2020 | Jun 28, 2019 | 269.10M | Aug 7, 2020 |
| FY2019 | Jun 29, 2018 | 287.17M | Aug 2, 2019 |
| FY2018 | Jun 30, 2017 | 291.80M | Aug 3, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2027 | Jun 27, 2025 | $600.00M | Aug 1, 2025 |
| FY2027 | Jun 28, 2024 | $585.00M | Aug 1, 2025 |
| FY2027 | Jun 30, 2023 | $582.00M | Aug 1, 2025 |
| FY2024 | Jul 1, 2022 | $610.00M | Aug 2, 2024 |
| FY2023 | Jul 2, 2021 | $649.00M | Aug 4, 2023 |
| FY2022 | Jul 3, 2020 | $673.00M | Aug 5, 2022 |
| FY2021 | Jun 28, 2019 | $713.00M | Aug 6, 2021 |
| FY2020 | Jun 29, 2018 | $726.00M | Aug 7, 2020 |
| FY2019 | Jun 30, 2017 | $561.00M | Aug 2, 2019 |
| FY2018 | Jul 1, 2016 | $727.00M | Aug 3, 2018 |